Crestline Management, LP Alkermes Plc. Transaction History

Crestline Management, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 12, 2020	SELL	$17.29 - $21.74 $1.77 Million - $2.23 Million	-102,500 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$19.51 - $24.28 $809,665 - $1.01 Million	41,500 Added 68.03%	102,500 $2 Million
Q2 2019 Aug 13, 2019	BUY	$21.47 - $37.33 $1.31 Million - $2.28 Million	61,000 New	61,000 $1.38 Million

362

181M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.9B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Crestline Management, LP, based on Form 13F filings with the SEC.

Stay updated on Crestline Management, LP with notifications on news.